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Chromosomal translocations are a major cause of cancer. At the same time, the mechanisms that lead to specific
chromosomal translocations that associate different gene regions remain largely unknown. Translocations are
induced by double strand breaks (DSBs) in DNA. Here we review recent data on the mechanisms of generation,
mobility and repair of DSBs and stress the importance of the nuclear organization in this process.Introduction
Many cancers are characterized by chromosomal translo-
cations. First evidence of translocations and their possible
role in cancer was put forward by German cytologist
Theodor Boveri 100 years ago, in 1914 [1]. Translocations
arise as a consequence of erroneous DNA double strand
break (DSB) repair. The DSBs appear during physiological
processes, such as recombination of immunoglobulin
genes in the course of lymphoid cell maturation, in patho-
logical processes and under the influence of external
conditions such as oxidative stress and ionizing radiation
(for review see [2]). A combination of several events is
required for a translocation to take place: these include
errors in DSB repair, spatial proximity of translocation
partners and the capacity of damaged loci to relocalize
within the nuclear space.
Currently, two hypotheses have been formulated to ex-
plain the proximity of damaged loci resulting in trans-
location events. The “contact first” hypothesis proposes
that the translocation partner loci are proximal within
the nucleus during the event leading to DSBs. The key
prediction of this model is close spatial proximity of
translocation partners [3]. This proximity may be per-
manent as in the case of RET and H4 loci [4] or tempo-
rary, as in the case of c-myc and immunoglobulin heavy
chain (IgH) loci when c-myc dynamically colocalizes with* Correspondence: vassetzky@igr.fr
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unless otherwise stated.IgH upon activation of B-lymphocytes [5]. This colocali-
zation may occur within specific nuclear compartments,
such as specialized repair foci (in yeast), transcription
factories, replication foci, and others (for review see [6]).
Positions of the chromosomes in the nuclear space
also affect the localization of potential translocation
partners. Gene-rich and small chromosomes tend to be
clustered in the center of the nucleus [7]; thus a prob-
ability of their direct contact is much higher than in the
case of larger chromosomes. The “contact first” hypoth-
esis postulates that the broken chromosome ends are
immobile or have a reduced mobility thus maximizing
the probability of the translocation of neighboring loci.
An alternative “breakage first” hypothesis postulates
that chromosome ends with DSBs can freely move
within the nuclear space and that collision of damaged
loci on different chromosomes may lead to transloca-
tions. In this case, the probability of translocation may
increase with the scale of DSB movement. This move-
ment can be either directed or stochastic, resembling
the Brownian motion of particles. The amplitude of sto-
chastic movements might increase after the DSBs thus
increasing the volume of the nuclear space scanned by
the damaged locus. The probability of collision of distant
loci followed by a translocation might also increase in this
case. A combination of both directed and stochastic move-
ments is also possible: the stochastic movement might
bring the locus in contacts with a structure, e.g. a nuclear
membrane, interchromosomal space or a perinucleolar re-
gion [8], and in this case the movement might become di-
rected and follow encountered structure.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tors, such as oxidative stress and ionizing radiation, but
they are also associated with physiological processes
such as DNA replication [9]. RAG1/2 and AID-induced
DSBs in immunoglobulin genes are required for V(D)J
recombination, somatic hypermutation and class switch
recombination essential for creation of antigen repertory
[10]. DSBs may also arise during viral infection [11]. In
yeast and higher eukaryotes, multiple DSBs arise at the
beginning of meiotic recombination [12].
In normal conditions, DSBs are repaired either by
homologous recombination (HR) which requires the
presence of the sister chromatid or by non-homologous
end joining (NHEJ), a direct ligation of damaged DNA
ends [13]. HR is a high fidelity mechanism, but it re-
quires the presence of a sister chromatid or homologous
sequences, therefore it is mostly used at late S/G2
phases of cell cycle and in meiosis. NHEJ is used in
other cases, and it is error-prone. It may lead to both
small errors at the DSB site and to translocation of large
DNA regions (for review see [14]). In the following sec-
tion we shall concentrate on DSBs and their repair that
potentially lead to translocations.
The movement of DSBs in the nuclear space could
be dependent on the break stability: both ends of a
DSB may stay associated before the translocation. In
case of the encounter of two neighboring loci with
DSBs, a reciprocal translocation may occur. Alter-
nately, a DSB may disturb the integrity of the chro-
mosome. The ends of the DSB separate and the
translocations events for each end become indepen-
dent. In this case, the translocations will not be recip-
rocal. Repair kinetics and the time of persistence of
DSBs also play a role in the mechanisms of translo-
cation. Indeed, persistent DSBs are more likely to pro-
duce translocations (reviewed in [15,16]).
Current methods of detection of DSBs and their mobility
Currently it is not yet clear whether DSBs lead to an in-
creased mobility of the damaged locus. The data both
confirming this hypothesis [4,17-21] and contradicting it
[22-24] exist (reviewed in [25,26]). This controversy may
be due to several factors, i.e. significant differences be-
tween the model systems used and the epigenetic pat-
terns of the models, various eukaryotic cell lines and
yeast. The methods of introduction of DSBs, the number
of induced DSBs, and the way to visualize the break and
measure its mobility may also affect the conclusions.
Other important factors to consider are the phase of the
cell cycle, the DSB localization in the genome, chroma-
tin context, the nature of the DSB, the presence of DNA
adducts and the mobility of the locus in the absence of
any damage and the mechanism of DSB repair. The role
of some of these factors is reviewed in [27].Translocations may be initiated by induction of a lim-
ited number of DSBs by ultrasoft X-rays, laser micro-
irradiation, γ-irradiation, α-particles. DSBs may also be
randomly induced by chemical agents, including topo-
isomerase poisons used in cancer therapy. Non-random
DSBs can now be induced using meganucleases and
TALEN nucleases. A direct comparison between results
obtained using different types of DSBs is possible only in
the case when the amount of generated DSBs and local
DSB densities are comparable [28]. Even in this case the
conclusions may be compromised by different nature of
DSBs, i.e. the absence or the presence of protruding ends
as well as the presence of covalently bound proteins in
case of DNA topoisomerase II-induced breaks may play
an important role in DNA mobility (see below).
DSBs can be easily detected in fixed cell preparations
using antibodies against DSB-specific proteins, DNA re-
pair proteins or by BrdU incorporation at the DSB site.
Of course, it is currently impossible to follow the move-
ments of a single damaged locus in a particular fixed
cell. The dynamics of DSBs and/or repair loci can only
be studied in this case by comparing the position of the
introduced break(s) to some control points at different
time points followed by statistical analysis. The mobility
of the damaged loci may also be followed by induction
of regularly spaced DSBs. This can be done by using an
irradiation-masking microgrid that allows to obtain a
regular pattern of DSBs and evaluate the mobility of
DSBs vs. this regular pattern [20]. The dynamics of a
DSB movement may also be studied by comparing its
position to positions of some specific loci using in situ
fluorescent hybridization (FISH).
A progress in time lapse microscopy allows now to
study the dynamics of DSBs in living cells in real time
[27,29]. Several approaches are used to visualize DSBs in
living cells: the cells can be transfected by vectors ex-
pressing one or several DNA repair factors fused to
fluorescent proteins. These factors assemble at the DSB
site and thus label the DSB. The dynamics of the DSB la-
beled this way can be followed during several hours.
Chromatin fluorescently labeled with GFP-H2B histone
may serve as a reference point to detect DSB movement
[17]. DSBs can be oriented along a straight line; in this
case the disturbance of the initial pattern suggests that
DSBs move within the nuclear space. The use of photo-
activated fluorescent proteins allows to introduce the
DSBs and to visualize them simultaneously [17].
The most sophisticated approach allows labeling in vivo
a unique site in the genome with a fluorescent probe, to
introduce a DSB and then follow the DSB movement. This
can be done by integrating into the genome a construct
containing the I-SceI recognition site surrounded by lacO
and/or tetO sites [22,30]. In cells producing I-SceI and
the corresponding fluorescently tagged repressors, the
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fluorescently labeled. This allows to visualize the trajectory
of the DSB up to the moment when it is repaired. This ap-
proach might be also used to study translocations when
two potential translocation partner loci are tagged with
different fluorochromes [30]. Unfortunately, the DSBs
induced by I-SceI are just a simplified model of what is
happening in real life; moreover the presence of multiple
lacO and/or tetO sites induces formation of heterochro-
matin structures and affects gene expression [31,32]. The
results obtained in such model systems may not directly
reflect real-life situation of genome damage and DNA
repair.
DSB mobility is estimated using mean square displace-
ment (MSD); MSD =Δx2(t), where x reflects the path of
the locus after DSB induction and t is time after DSB in-
duction. MSD also depends on the viscosity of the
medium via a diffusion coefficient. MSD analysis allows to
determine the volume of nucleus scanned by the locus
with the DSB. If the mobility of the locus is restricted, the
MSD value rapidly reaches a plateau.
Relative mobility of two loci can be characterized by
mean square change in distance (MSCD). This method
implies that the mobility of both loci has a similar pattern,
which is not always the case [24,26].
DSB mobility in yeast: a role in DNA repair?
There is a significant difference between the behavior of
DSBs in yeast and in higher eukaryotes: in yeast, DNA is
repaired in specific nuclear compartments, repair foci.
The damaged loci may be relocated into these repair foci
as observed in [33]. Higher eukaryotes do not possess a
specific repair compartment, therefore the damaged locus
remains relatively immobile and repair factors move
towards it to assemble on the DSB site. The increase in
mobility of the damaged locus in this case occurs mostly
because of the increase of the amplitude of Brownian mo-
tion and local chromatin decompaction at DSB site.
Large-scale and directed movements are rare events that
occur in particular areas and in case of complex DNA
damage [6].
A relative consensus exists on the mobility of damaged
loci in yeast: several DSBs assemble at Rad52-containing
repair foci [33], suggesting that the damaged loci are
highly mobile in the nuclear space and form clusters. In-
deed, introduction of DSBs is accompanied by the in-
crease in mobility of damaged loci [22,24]. A four-fold
increase in locus mobility was observed upon introduc-
tion of a DSB, but not a single-stranded break in haploid
cells, and a two-fold increase, in diploid cells [24]. The
damaged locus scanned ~30% of the nuclear volume in
diploid cells [22,24], and 47%, in haploid cells [22]. The
undamaged locus could scan ~12% of the nuclear vol-
ume; this did not depend on the position of the targetlocus in the genome. In some cases, a DSB in one allele
led to an increased mobility of the undamaged allele
[24], in other cases, no effect on the mobility of undam-
aged loci was observed [22]. Increased mobility of the
damaged locus might be specific for diploid cell and re-
quired for the sister chromatid search and repair.
Large-scale movement of damaged loci is specific for
persistent DSBs. These DSBs are particularly dangerous
for the cells. In yeast, persistent DSBs move towards the
nuclear periphery through association with Mps3, tel-
omerase and proteins of the nuclear pore complex [34].
DSBs in the telomeric regions are also sequestered in
the nuclear periphery [35,36]. It is yet unclear why
persistent DSBs are recruited to the perinuclear region,
possibly this recruitment is required to isolate them or
delay their replication. This relocalization may also rep-
resent an attempt to repair these DSBs in a specialized
compartment using alternative repair mechanisms.
Mobility of DSBs in yeast cells is mediated by several
protein factors: key repair enzymes RAD51, Sae2,
RAD54, Mec1, and RAD9 [22,24,37]. Recruitment of a
persistent DSB to the nuclear periphery also depends on
H2A.Z [38]. It is unclear whether DSB relocation is an
ATP-dependent process.
Importantly, the damaged locus moves as a whole and
the damaged ends remain associated within the locus
[33,39,40]. DSB stabilisation in this case is mediated by
the MRX complex and exonuclease I that processes DSB
ends before DNA repair [41].
DSB mobility in higher eukaryotes
In contrast to yeast, the published data on mobility of
DSBs in higher eukaryotes are quite controversial. Mo-
bility of DSBs induced by X-rays or γ-irradiation did not
differ from that of intact loci [18-21], reviewed in [25]).
In most cases, very restricted movement of damaged loci
was observed (with a diameter less than 0.5 μm, com-
pare with an average diameter of the nucleus of 10 μm).
Large scale-movements (>5 μm) were observed in a mi-
nority of nuclei (<2%) with altered nuclear morphology.
The mobility of damaged loci did not depend on the
used irradiation source and the number of induced DSBs
[19]. Similar results were obtained in cells irradiated with
an argon laser (364 nm) where DSBs were immobile and
did not form clusters [17]. A local ATP-dependent
decondensation of chromatin was observed at DSB sites
in this case.
The majority of the I-SceI-induced single DSBs also did
not change their position in the nuclear space [21]. It
should be noted that restricted mobility of the locus in this
case might be due to the presence of lacO binding
proteins at the DSB site. The large size of the resulting
complex might decrease the diffusion of the complex in
the nucleus. Stability of the I-SceI-induced DSBs was
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At the same time, the absence of Ku80 led to an increase
in a number of cells where the DSB ends were dislocated,
moreover, Ku80 knockdown increased the mobility of the
damaged locus from 50 to 80 nm/min [21].
The opposite results on relocalization and clusteriza-
tion of loci with DSBs were obtained by Aten et al., [23].
Cells were irradiated with α-particles so that DSBs were
localized along a straight line, so that any subsequent
DSB movement would disturb the initial linear pattern.
The DSBs were detected by immunostaining with anti-
bodies against phosphorylated H2AX. Alteration of the
linear pattern could already be observed five minutes after
DSB induction. DSB clustering was observed, mostly in
G1 cells, while in S and G2 phase cells no clustering was
revealed, but a part of damaged loci moved at distances up
to 2 μm. Cells, deficient in one of repair pathways (HR or
NHEJ) had a similar pattern of DSB mobility. Inactivation
of XRCС-3 and inhibition of DNA-PK did not affect clus-
tering of damaged loci [42], suggesting that relocalization
and clustering of DSBs are not linked to DNA repair. In-
deed, repair factors such as MRN complex, Ku80 and
DNA-PK mostly ensure the DSB stability [43], with the
exception of Rad51 which is capable to actively relocate
chromatin fibres [44]. Below we shall consider two other
important players in DSB mobility, large-scale nuclear
organization and chromatin.
DSB mobility and chromatin
Chromatin context in the damaged locus may signifi-
cantly affect DSB mobility. Histone variant incorpor-
ation, histone post-translational modifications, and ATP-
dependent chromatin remodelling - three major strat-
egies for chromatin manipulation - may occur at DSBs
(reviewed in [45,46]). Histone variants (H2AX and H2A.
Z), histone post-translational modifications (acetylation,
phosphorylation, methylation and ubiquitination) and
chromatin-remodeling complexes (INO80, SWR1, SWI/
SNF, RSC and NuRD) are important and direct players
in cellular responce to DSB. Changes of the chromatin
status of the damaged locus may lead to two conse-
quences: signaling and decompaction/remodeling of the
chromatin fiber to increase the accessibility of the DSB
for the repair machinery. Indeed, nucleosome eviction
and sliding as well as exchange of histones in chromatin
are required for DSB repair [45,46].
How chromatin remodelling at DSB can affect the locus
mobility? This subject has been extensively studied during
the past few years (for review see [46-49]). Chromatin re-
modeling is necessary both for NHEJ and HR. In case of
HR, active nucleosome eviction occurs at DSB followed
by formation of single-stranded DNA. Nucleosome-free
DNA has a higher mobility than chromatin (Figure 1). In
yeast, deletion of arp8, which impairs INO80-dependentremodeling, leads to decreased mobility of a DSB [50]. In
higher eukaryotes, a p400 SWI/SNF ATPase of the TIP60
complex provokes nucleosome destabilization around
DSB [51]. At the same time, inhibition of the major chro-
matin remodelling factor at DSBs, Tip60 did not affect
DSB mobility [52].
Another factor that can potentially affect DSB mobility
is chromatin decompaction in the damaged locus
(Figure 1). Chromatin decompaction after a DSB is ac-
companied by the changes in chromatin fibre mobility,
increase in the volume occupied by the locus and thus
an increase in passive mobility of the damaged locus. On
the other side, chromatin decompaction may not be ac-
companied by increased DSB mobility [17].
Phosphorylation of the H2AX histone is one of the
early responses of the cell to DNA damage. Phosphory-
lated H2AX (γH2AX) is spread over several megabases
on both sides of a DSB, and attracts the MRN complex.
This is followed by accumulation of 53BP1, RAD51,
Nbs1, BRCA1 and chromatin remodeling complexes
(INO80 и SWR1) at the DSB site (reviewed in [53,54]).
Besides this, H2AX phosphorylation changes the folding
of a chromatin fiber by destabilizing the interaction be-
tween DNA and the H2AX-H2B dimer [55]. This results
in formation of a relaxed chromatin domain where the
damaged locus can have an increased mobility. Another
histone variant, H2A.Z participates in relocalization of non-
repaired DSBs to the nuclear periphery, where the DSBs
are sequestered. The DSB relocalization is dependent on
sumoylation of the C-terminus of H2A.Z [56].
Unfolding of a damaged locus is also due to DSB-
induced post-translational modifications of all core his-
tones (reviewed in [45]). Histone acetylation plays an im-
portant role in formation of a relaxed chromatin domain
and an increase in DSB mobility. In yeast, DSBs lead to
rapid acetylation of H4K16 followed by decompaction of
the 30 nm chromatin fiber or other higher-order chro-
matin structures. This is followed by acetylation of other
H4 residues (H4K5, H4K8ac, H4K12) that further relax
chromatin. Epigenetic modifications at the original sites
of DSBs showed local chromatin decondensation mani-
fested by increased H4K5 acetylation and decreased
H3K9 dimethylation [18,57]. Decondensation of chro-
matin near DSB is accompanied by accumulation of
acetylated H4K5 and H4K12, these signal partially coin-
cided with the region enriched in γH2AX. Moreover,
heterochromatin-associated persistent DSBs have a lower
mobility than rapidly repaired DSBs [58]. An alternative
model predicts higher mobility of heterochromatin-
associated DSBs since establishment of a repair-competent
focus may require its relocation into a “chromatin hole”
where chromatin is relaxed [6]. The data on the role of
chromatin in DSB mobility are quite controversial. Global
changes in chromatin organization after cell treatment with
Figure 1 Introduction of a DSB may increase chromatin mobility at DSB by formation of a nucleosome-free loop (A) or by chromatin
decompaction (B). Acetylated histones are marked with yellow dots.
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and histone deacetylases significantly decreased the mobi-
lity of damaged loci and their clusterization [58]. At the
same time, inhibition of the major chromatin remodelling
factor at DSBs, Tip60 did not affect DSB mobility [52].
It is likely that a specific chromatin organization at
and around the DSB site regulates repair by creating a
specific compartment that coordinates DNA repair. The
increase in DSB mobility may be due to gradual restruc-
turing of chromatin in this repair-competent compart-
ment. The probability of translocation may depend not
on the collision of broken chromosome ends, but rather
on a collision and fusion of repair-competent chromatin
domains. The latter seems more likely. If these chroma-
tin domains are structured, their fusion in a single com-
partment makes translocation a highly probable event.
DSB mobility and large scale chromatin organization
Multiple DSBs are particularly dangerous since they may
lead to translocations, but even isolated DSBs may pro-
duce massive damage to cell if they are located in re-
gions that ensure structural and functional integrity of
the genome. When a limited number of DSBs are intro-
duced in DNA, the mobility of the damaged locus may
be limited by a chromatin domain or a subcompartment,
and thus depend on chromatin organization and the
genome architecture. Currently there are several models
of nuclear organization, most of these models predict
the existence of chromatin domains separated by specific
border elements (for review see [59,60]). A nuclear
matrix model predicts the existence of ubiquitous nu-
clear skeleton [60], some authors propose that thenucleus is structured by lamin-associated domains [61],
and recent genome-wide chromatin conformation stu-
dies put forward the model of organization of nucleus
into globular domains separated by linkers [62,63]. Inte-
restingly, all these models imply a key role of certain
proteins in structuring the nucleus [64-67]. Lamin is one
of these proteins and it also participates in ensuring the
stability of DSBs [68]. It is likely that locus mobility is
restricted to a specific topological domain, where folding
of its elements inhibits the mobility of damaged loci.
This aspect of DSB mobility remains largely unknown.
Large-scale DSB movements may be mediated by
molecular motors (nuclear actin and myosin), although
currently there are no experimental data supporting this
point of view.
When multiple and clustered DSBs are introduced into
DNA, DSBs in key regions responsible for chromatin
folding may destabilize the nuclear organization, thus
greatly increasing the DSB mobility (Figure 2). These
key regions may include the sites of DNA attachment to
the nuclear matrix or regions involved in interaction in a
chromatin globule (Figure 2). Such clustered DSBs are
produced by high-energy α-particles and energy transfer
induced by α-particles may indeed destabilizes nuclear
structures and thus induce DSB clusterization. At the
same time, data obtained on cell irradiated with low-
energy γ-irradiation confirmed the observations obtained
with α-particles [58]. DSBs were tagged in this case with
53BP1-GFP tagged protein. γ-irradiation induced forma-
tion of 53BP1-GFP foci and mobility of intact and dam-
aged loci were studied using time lapse microscopy. A
two-fold difference was observed in the nuclear volumes
Figure 2 Introduction of a DSB may perturb higher-order chromatin organization by targeting nuclear matrix attachment sites (A) or
chromatin hub organizer sequences (B).
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were induced by γ-irradiation, and a three-fold difference
was observed when DSBs were induced by topoisomerase
II inhibitor etoposide. Inhibition of transcription did not
affect the mobility of the damaged locus while ATP deple-
tion decreased the mobility by 34%. The authors proposed
that the damaged locus mobility was due to local chroma-
tin decondensation and formation of a relaxed chromatin
domain at DSB sites.
Mobility of DSBs induced by topoisomerase II inhibitors
DNA topoisomerase II is an essential enzyme regulating
DNA and chromatin topology. DNA topoisomerase II
functions by forming a covalent complex with DNA,
introducing a DSB and resealing the cleaved molecule
[69,70]. DNA topoisomerase II is an excellent target in
cancer therapy [71,72]. Topoisomerase poisons fix the
covalent complex and inhibit religation of a DSB [69].Stalled DNA-DNA topoisomerase II complex is then
converted into a DSB and cell death followed DSB accu-
mulation [72,73]. Unfortunately, while being powerful
and efficient anticancer drugs, topoisomerase poisons
also induce secondary leukaemia due to high-frequency
induction of translocations [74-76]. The frequency of
these translocations obviously should depend on repair
errors, on spatial proximity of the translocation partners
and on mobility of the damaged loci.
Chromosomal breakpoints are clustered in so-called
breakpoints cluster regions (bcr) in topoisomerase II
poison-induced translocations [77,78]. In normal condi-
tions, DSBs including topoisomerase II-induced ones are
repaired either by NHEJ or by HR [79-82]. Transloca-
tions arise from the NHEJ, and a specific type of NHEJ
that is activated in case of DSB persistence might be re-
sponsible for the majority of translocations [83]. The
translocations occur when correct joining of the DSB
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complexity, rapid destabilization of the DSB site and dis-
joining of the damaged ends or defects in DNA repair.
Etoposide can trigger illegitimate recombination and
translocations [82,84].
Approximately 20-30% of therapy-related hematologic
diseases contain balanced chromosomal translocations
[85]. Treatment-related translocations mostly lead to ex-
pression of chimeric genes involved in regulation of
haematopoiesis [86]. In many cases, these translocations
concern MLL and AML1 genes that translocate with a
wide range of partners (http://atlasgeneticsoncology.org/)
[78]. Currently there are no serious arguments in favour
of the “contact first” or the “breakage first” hypotheses to
explain the mechanism of these translocations. Analysis of
nuclear localization of AML1 and its most frequent trans-
location partner ETO1 demonstrated that their colocaliza-
tion frequency increased from 4.8% to 9.9% after
treatment with topoisomerase poison etoposide [87,88].
The frequency of colocalization of MLL and its partners in
the nuclear space was shown to be inversely proportional
to the MLL/AF4 and MLL/ENL translocation frequency
[89]. It has recently been shown that the frequency of
MLL colocalization with its translocation partners AF9 or
AF4 in one transcription factory did not exceed 2-3%, be-
ing almost a random event [90]. 3D FISH analysis of MLL
locus revealed several interesting observations: at least in
17% of etoposide-treated cells, topoisomerase II-induced
DSB was converted into a chromosomal break with two
DSB ends being distant in the nuclear space; the frequency
of this situation increased when etoposide was removed
and the cell could repair the DSB [8]. Position of these
breaks was significantly different from that of non-
damaged loci: immediately after etoposide treatment, the
DSB in MLL locus was localized within the chromosomal
territory of chromosome 11, but after 1 hour chase, ~9%
of the damaged loci moved outside their chromosomal
territory, this behaviour was MLL-specific, other genes
remained confined to their chromosomal territories after
etoposide treatment [8].
Interestingly, a single bcr-targeted DSB in the MLL gene
introduced by a Zn-finger nuclease was also converted
into a chromosomal break [91]. Inhibition of DNA-PK in-
creased the probability of dissociation of the damage locus
ends four-fold. Unfortunately it is difficult to directly com-
pare the mobility of a single nuclease-induced DSB and
multiple DSBs induced by etoposide. Interestingly, the Zn-
finger nuclease induced DSB in the bcr did not induce
translocations [91], suggesting that a single DSB is not suf-
ficient. Moreover, the probability of translocation may also
increase in case of problems with DNA repair of complex
DSBs. Topoisomerase poison-induced DSBs that arise in
the MLL bcr may be clustered and heterogeneous, some
are introduced by topoisomerase II, leaving DNA endbound via the topoisomerase II subunits; these can be
converted into DSBs after ubiquitin-26S proteasome pro-
teolysis of topoisomerase II [92,93]. The bcr region is also
a target of apoptotic nucleases, and apurinic and apyrimi-
dinic sites may arise in the region from oxidative stress in-
duced by etoposide [94]. Such complex clustered damage
could be difficult to repair and leads to DSB persistence.
Non-repaired DSB converted into a chromosomal break is
a serious danger to the genome integrity.
Importantly, most translocations concerning MLL are
reciprocal [95], and only a DSB that was not converted
into a chromosomal break can produce a reciprocal
translocation; thus large-scale mobility of the damaged
locus may not give rise to translocations or produce
non-reciprocal translocation that may lead to secondary
leukaemias.
DSB mobility and reciprocal vs. non-reciprocal
translocations
An interesting insight on mobility of DSBs might be ob-
tained from the analysis of primary translocations in
cancer. Indeed, reciprocal translocations occur when
both partner loci have DSBs that are not converted into
a chromosomal break. Such translocations are character-
istic for Non-Hodgkin lymphomas and leukaemias.
DSBs followed by chromosomal breakage mostly produce
non-reciprocal translocations. Primary non-reciprocal
translocations are characteristic of epithelial tumours
[96] and solid tumours, e.g. renal cancer [97]. It must
also be noted that the frequency of non-reciprocal
translocations increases with progression in most types
of cancer, but discussion of this topic is out of scope of
the present review.
Therefore, a caution must be taken when applying re-
sults on DSB mobility obtained on one cell line to other
cell types and tissues. Moreover, some results that we have
reviewed above have been obtained on cancer cell lines
that might be prone to specific types of translocation.
Other factors might induce translocations, e.g. telomeric
dysfunction provokes appearance of non-reciprocal trans-
locations in epithelial cells [98]. Telomere shortening
might increase the DSB mobility and thus lead to chromo-
somal breaks at DSBs. The appearance of multiple translo-
cations after a genotoxic stress may be linked to an
increased DSB mobility and clusterization [99].
Conclusions
Results obtained with different DSB models in higher
eukaryotes are often inconsistent. Indeed, single DSBs
are rarely converted into a chromosomal break. In this
situation, an increase in the locus mobility is mostly
linked to chromatin decompaction [46] that increases
diffusion of the damaged loci. Multiple and clustered
DSBs are frequently converted into a chromosomal
Iarovaia et al. Molecular Cancer 2014, 13:249 Page 8 of 10
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case; alternately, multiple DSBs might disturb the nu-
clear architecture (nuclear matrix, lamin-associated do-
mains or chromatin globules). This global disaster might
delocalise both damaged and non-damaged loci and
greatly increase the DSB mobility.
Studies of DSB mobility, its mechanisms and factors
are important for better understanding of the mecha-
nisms of translocations. A directed reduction of DSB
mobility upon X-ray irradiation or DNA-damaging drug
treatment may reduce a risk of secondary translocations
in cancer.
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